---
title: "KEYMED BIO-B  Swings to Interim Profit of RMB1.218 Billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296421813.md"
description: "KEYMED BIO-B+5.200 (+6.749%) Short selling $12.22M; Ratio 12.910% announced its interim results for the six months ended June 2026. Revenue amounted to RMB617 million, up 24% YoY. The company swung to a profit of RMB1.218 billion from a loss of RMB78.79 million in the corresponding period last year. EPS was RMB4.29. No dividend was declared. (ad/)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-19 16:25.) AASTOCKS Financial News"
datetime: "2026-08-20T01:46:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296421813.md)
  - [en](https://longbridge.com/en/news/296421813.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296421813.md)
generator: "portal-rs"
---

# KEYMED BIO-B  Swings to Interim Profit of RMB1.218 Billion

KEYMED BIO-B (02162.HK) +5.200 (+6.749%) Short selling $12.22M; Ratio 12.910% announced its interim results for the six months ended June 2026. Revenue amounted to RMB617 million, up 24% YoY. The company swung to a profit of RMB1.218 billion from a loss of RMB78.79 million in the corresponding period last year. EPS was RMB4.29. No dividend was declared. (ad/)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-19 16:25.)  

AASTOCKS Financial News

### Related Stocks

- [02162.HK](https://longbridge.com/en/quote/02162.HK.md)

## Related News & Research

- [Keymed Biosciences licenses Stapokibart marketing, sales rights in 18 Southeast and Central Asia markets to Aeira](https://longbridge.com/en/news/297791065.md)
- [Keymed Biosciences plans RMB share listing on Shanghai STAR Market](https://longbridge.com/en/news/296363752.md)
- [ADF Group declares CAD 0.02 dividend](https://longbridge.com/en/news/298599709.md)
- [YieldMax MSTR Performance & Distribution Tg 25 ETF declares $0.1345 dividend](https://longbridge.com/en/news/298920067.md)
- [InterDigital raises dividend by 7% to $0.75](https://longbridge.com/en/news/298541242.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**